These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25515688)

  • 21. [Osmotic resistance of erythrocytes as a screening method in detecting heterozygotes in beta-thalassemia].
    Nastev B; Efremov GD; Petkov G
    Bilt Hematol Transfuz; 1977; 5(3-4):89-94. PubMed ID: 615615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of single-tube osmotic fragility test and its different methods as screening test for thalassemia trait: an alternative to expensive laboratory tests for resource-limited countries.
    Ansari SH; Hanifa A; Saleem A; Ali SM; Hussain Z; Zohaib M; Akbar M; Rehman S; Hussain SR
    Eur J Haematol; 2014 Dec; 93(6):516-20. PubMed ID: 24912950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing NESTROFT as a preliminary screening tool for thalassemia in the Malayali tribes of Dharmapuri district, Tamil Nadu, India.
    Pichamuthu BG; Arunachalam KD; Kosalram K
    J Family Med Prim Care; 2024 Jul; 13(7):2767-2771. PubMed ID: 39071022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
    Mamtani M; Das K; Jawahirani A; Rughwani V; Kulkarni H
    J Med Screen; 2007; 14(4):169-73. PubMed ID: 18078560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy: an alternative approach to electronic blood cell counting.
    Sanchaisuriya K; Fucharoen S; Fucharoen G; Ratanasiri T; Sanchaisuriya P; Changtrakul Y; Ukosanakarn U; Ussawaphark W; Schelp FP
    Am J Clin Pathol; 2005 Jan; 123(1):113-8. PubMed ID: 15762286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and molecular basis of beta-thalassemia in Isparta province and region.
    Tunç B; Cetin H; Gümrük F; Istanbullu B; Yavrucuoğlu H; Kurt U; Genç H
    Turk J Pediatr; 2002; 44(1):18-20. PubMed ID: 11858373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.
    Sirichotiyakul S; Tantipalakorn C; Sanguansermsri T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):347-50. PubMed ID: 15325851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment of Method for Detecting Red Blood Cell Osmotic Fragility by Flow Cytometry].
    Zhu HY; Meng Q; Ouyan HM; Dong T; Zhang QY; Zhou YQ; Ping ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):229-32. PubMed ID: 26913426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two screening methods, modified Hb H preparation and the osmotic fragility test, for alpha-thalassemic traits on the basis of gene mapping.
    Lin CK; Yang ML; Jiang ML; Chien CC; Lin HH; Peng HW
    J Clin Lab Anal; 1991; 5(6):392-5. PubMed ID: 1723096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Chen WQ; Lin FQ
    Ann Hematol; 2015 May; 94(5):747-51. PubMed ID: 25501660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
    Wiwanitkit V; Suwansaksri J; Paritpokee N
    Clin Lab; 2002; 48(9-10):525-8. PubMed ID: 12389713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of isoelectric focusing and high performance liquid chromatography in neonatal cord blood screening for thalassemia and non-sickling hemoglobinopathies.
    Uaprasert N; Settapiboon R; Amornsiriwat S; Sarnthammakul P; Thanapat T; Rojnuckarin P; Sutcharitchan P
    Clin Chim Acta; 2014 Jan; 427():23-6. PubMed ID: 24095765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic strategy for thalassemias and other hemoglobinopathies: a program applied to the Hellenic Army recruits.
    Tegos CN; Voutsadakis AJ; Karmas PA
    Mil Med; 1992 Apr; 157(4):183-5. PubMed ID: 1620378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study.
    Nathalang O; Nillakupt K; Arnutti P; Boonsiri T; Panichkul S; Areekul W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S35-42. PubMed ID: 16862674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of hyperdense cells: Automated parameter to hereditary spherocytosis screening.
    Farias MG; Freitas PA
    Clin Biochem; 2015 Dec; 48(18):1341-3. PubMed ID: 26210847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of alpha(0)-thalassemia screening using combined osmotic fragility, dichlorophenolindophenol and Hb H inclusion tests.
    Chaibunruang A; Pornphannukool S; Sae-Ung N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Clin Lab; 2010; 56(3-4):111-7. PubMed ID: 20476642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of red cell mean corpuscular volume and simple tube red cell osmotic fragility quantitative test in detection of thalassemia].
    Deng J; Liu X; Liu Y
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):610-2. PubMed ID: 11372413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of Extended Family Members of Thalassemia Major Children as a Thalassemia Preventive Strategy.
    Sonkawade ND; Kinikar AA; Kulkarni RK; Dawre RM; Valvi CT; Kamath PA
    Ethiop J Health Sci; 2022 Nov; 32(6):1203-1210. PubMed ID: 36475260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.